Ani Pazhava

4PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2025
Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP-GEP (Merlin) Versus 31-GEP (DecisionDx-Melanoma).

Domenico Bellomo, Christian Gross, Ani Pazhava

|May 15, 2025
The Role of Stromal Tumor Environment in Advancing Skin Cancer Diagnosis and Treatment.

Frank Jing, Ani Pazhava, Catherine Shachaf

|Aug 18, 2024
31-GEP (DecisionDx): a review of clinical utility and performance in a Mayo Clinic cohort.

Ani Pazhava, Yong-Hun Kim, Frank Z Jing

|Jun 13, 2024
Statin use does not impact sentinel lymph node metastasis and recurrence in melanoma patients: an 844-patient retrospective study.

Frank Z Jing, Ani Pazhava, Austin Todd

Pageof 1

Frequent Collaborators

3 joint publications

Frank Z Jing

3 joint publications

Alexander Meves

1 joint publications

Wesley Y Yu

1 joint publications

Catherine Shachaf